Apple just crossed a threshold no American company has ever reached, and Wall Street is split on whether the stock can keep climbing from here or whether the milestone itself signals a ceiling.
Ford surged past both Detroit and Silicon Valley rivals in a single session, driven by a confluence of factors that rarely align this cleanly for a legacy automaker carrying fresh EV write-downs and a…
Both IBM and Verizon carry decades of unbroken dividends and trade at a discount to the broader market, but the gap between them on the metrics retirement investors actually care about is far larger…
Not every fat dividend yield is worth chasing into retirement, and the difference between a durable income stream and a yield trap often hides in details most investors skip past entirely.
JPMorgan's BBUS just priced itself below VTI, but the fee advantage comes with a quiet omission that changes the whole comparison, and whether it costs you or pays you depends on where your money…
Retirement means living off your portfolio, not waiting for it to grow, and right now five familiar dividend giants are trading at prices that Wall Street considers deeply undervalued.
The Fed stays silent, Saudi jets are striking Iran, and Wall Street is somehow holding its breath without falling apart. Find out what Wells Fargo just told clients about Snowflake and why today's crossfire…
Bill Ackman runs a concentrated quality portfolio. David Tepper trades distressed assets and macro trends. When two billionaires with completely opposite investing styles both stack more than 15% of their capital into the same…
Wall Street analysts reshuffled their bets on Wednesday with a wave of upgrades, downgrades, and fresh initiations spanning energy, autos, crypto infrastructure, and quantum computing. Find out which names got boosted and which got…
Archer Aviation has gone from retail darling to distressed asset trading near multi-year lows, and a short list of corporate giants already has the motive, money, and strategic logic to make a move before…
Medicare's new $50 monthly Wegovy program sounds like a lifeline, but the eligibility rules quietly shut out many of the people who expect to qualify first, including some with common diagnoses who assume they…
SK Hynix just posted the most explosive profit growth any chipmaker has seen in years, yet investors responded by selling the stock below its IPO price. The reason reveals something unsettling about where the…
FDA calendars are stacking up fast, obesity Phase 3 data is closing in, and three biotech names spanning the risk spectrum are quietly positioning for a pivotal back half of 2026.
Every year a dual-earner couple keeps maxing their traditional 401(k) in their late 50s, they quietly widen a pipe that federal tax law will eventually force open all at once, and the damage lands…
Trump wants the lowest interest rates in the world, but his own Fed chair faces a committee that is split between holding and raising them. Today's decision will reveal whether Kevin Warsh serves the…